Product Information
OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5 is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $1.1322 per EA under NDC 33342024610. Its NADAC has been published 36 times since Dec 17, 2025.
FDA first approved this application on Jul 18, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5
Olmesartan medoxomil Amlodipine and HydrochlorothiazideStrength
10; 12.5; 40 mg/1; mg/1; mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342024610
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA207088FDA Approved
7/18/2025
TE Code
AB
On Market Since
7/18/2025
Pharmacological Classes
Price Statistics
The NADAC for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5 has been published 36 times since Dec 17, 2025, and over the history we have for it it has declined 18.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1322 per EA |
|---|---|
| All-time high | $1.4139 (Jun 10, 2026) |
| All-time low | $1.1322 (Aug 19, 2026) |
| 52-week high | $1.4139 |
| 52-week low | $1.1322 |
| Median price | $1.3412 |
| Average price | $1.3273 |
| Largest weekly change | +9.4% (Apr 22, 2026) |
| Weeks tracked | 36 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5?
The current National Average Drug Acquisition Cost (NADAC) for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5, manufactured by Macleods Pharmaceuticals Limited, is $1.1322 per EA (NDC 33342024610), effective Aug 19, 2026.
How has the price of OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5 changed over time?
Over the history we have for it, the NADAC for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5 has declined 18.2%. It has been tracked across 36 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5?
Since Dec 17, 2025, the NADAC for OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5 has ranged from a low of $1.1322 (Aug 19, 2026) to a high of $1.4139 (Jun 10, 2026), with a median of $1.3412 per EA.
Are there cheaper alternatives to OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5 in a comparable dosage form, but none are currently priced below it.
Who manufactures OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5?
OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5 (NDC 33342024610) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.